Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Azarnoff

Showing results (11-20 of 116) with videos related to

Pageof 12
Sort By:
Federation Proceedings|May 1, 1971
Pharmacology of hypolipidemic drugs. IntroductionD L Azarnoff
American Pharmacy|August 1, 1982
Nitroglycerin patches: further commentsA Karim, D L Azarnoff
Clinical Pharmacokinetics|January 1, 1976
Drug protein binding and the nephrotic syndromeR Gugler, D L Azarnoff
Annals of the New York Academy of Sciences|January 1, 1976
Clinical principles of drug interactions in the adult patientA Hurwitz, D L Azarnoff
Rational Drug Therapy|November 1, 1976
The clinical use of plasma drug concentrationsR Gugler, D L Azarnoff
Pharmacology for Physicians|February 1, 1970
Drug interactionsD L Azarnoff, A Hurwitz
Life Sciences|January 15, 1977
Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicyclic acid in sewage water effluentC Hignite, D L Azarnoff
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1975
Diphenylhydantoin potency and plasma protein bindingD W Shoeman, D L Azarnoff
Pharmacology|January 1, 1972
The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoinD W Shoeman, D L Azarnoff
Federation Proceedings|May 1, 1971
Effects of selected hypolipidemic drugs on cell ultrastructureD J Svoboda, D L Azarnoff
Pageof 12

Showing results (11-20 of 116) with videos related to

Sort By:
Pageof 12
Federation Proceedings|May 1, 1971
Pharmacology of hypolipidemic drugs. IntroductionD L Azarnoff
American Pharmacy|August 1, 1982
Nitroglycerin patches: further commentsA Karim, D L Azarnoff
Clinical Pharmacokinetics|January 1, 1976
Drug protein binding and the nephrotic syndromeR Gugler, D L Azarnoff
Annals of the New York Academy of Sciences|January 1, 1976
Clinical principles of drug interactions in the adult patientA Hurwitz, D L Azarnoff
Rational Drug Therapy|November 1, 1976
The clinical use of plasma drug concentrationsR Gugler, D L Azarnoff
Pharmacology for Physicians|February 1, 1970
Drug interactionsD L Azarnoff, A Hurwitz
Life Sciences|January 15, 1977
Drugs and drug metabolites as environmental contaminants: chlorophenoxyisobutyrate and salicyclic acid in sewage water effluentC Hignite, D L Azarnoff
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1975
Diphenylhydantoin potency and plasma protein bindingD W Shoeman, D L Azarnoff
Pharmacology|January 1, 1972
The alteration of plasma proteins in uremia as reflected in their ability to bind digitoxin and diphenylhydantoinD W Shoeman, D L Azarnoff
Federation Proceedings|May 1, 1971
Effects of selected hypolipidemic drugs on cell ultrastructureD J Svoboda, D L Azarnoff
Pageof 12